Transition to newer clot-busting drug improves patient outcomes, lowers cost in treating ischemic stroke

A newer-generation stroke drug is outperforming the standard clot buster. A neurologist explains how tenecteplase saves both time and money when it comes to treating ischemic stroke.

from Latest Science News -- ScienceDaily https://ift.tt/C3Pn69V